NEW YORK (GenomeWeb News) – Bruker today reported a 14.9 percent increase in first-quarter revenues, aided by a 9.9 percent currency benefit, but posted a loss due to $5.8 million in acquisition charges.
 
The Billerica, Mass.-based firm reported revenues of $238.4 million for the three-month period ended March 31, compared to revenues of $207.5 million in the first quarter of 2007. Bruker’s product revenues rose to $207 million from $181.6 million year over year, while service revenues increased to $30 million from $25.2 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.